Physiol Rev 95:513548 Sisley S, Gutierrez-Aguilar R, Scott M, D'Alessio DA, Sandoval DA, Seeley RJ (2014) Neuronal GLP1R mediates liraglutides anorectic but not glucose-lowering effect
This is where GLP-1 receptor agonists (medications like semaglutide and tirzepatide) may offer an additional benefit beyond weight loss
2019;92(23):e266173
PubMed Crew KD, Brown P, Greenlee H, Bevers TB, Arun B, Hudis C, McArthur HL, Chang J, Rimawi M, Vornik L, Cornelison TL, Wang A, Hibshoosh H, Ahmed A, Terry MB, Santella RM, Lippman SM, Hershman DL
The inclusion of patients with severe asthma in registries will provide clinicians with information on long-term safety, and the longer-term follow-up of patients treated with biologics is crucial to verify the lack of subsequent occurrences